J Rheum Dis.  2025 Jan;32(1):17-29. 10.4078/jrd.2024.0062.

Efficacy of Curcuma longa in relieving pain symptoms of knee osteoarthritis patients: a systematic review and metaanalysis of clinical trials

• Hidayat R
• Parlindungan F
• Nisa JI
• Mahendra AI
• Indika MI
• Efendi C

• KMID: 2562656
• DOI: http://doi.org/10.4078/jrd.2024.0062

Abstract

Objective
Osteoarthritis (OA), particularly knee OA, affects 24% of adults and is a significant cause of disability. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used but have many adverse effects. Antioxidant and anti-iflammatory properties of Curcuma longa might decrease pain thus improving joint function.
Methods
This systematic review and meta-analysis evaluated randomized controlled trials (RCTs) on Curcuma longa efficacy for knee OA. We reported mean differences (MD) with 95% confidence interval (CI) for continuous outcomes and evaluated Visual Analog Scale (VAS) for pain and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) total score over 4 to 6 weeks for treatment effects.
Results
Ten RCTs with 786 patients were included. Curcuma longa significantly improved VAS for pain than placebo (MD: 18.25, 95% CI: 7.79 to 28.72, p=0.0006). It was not inferior to NSAIDs in WOMAC total score improvement (MD: –11.99, 95% CI: –39.21 to 15.23, p=0.39). Both dosages (<1,000 and ≥1,000 mg/day) of Curcuma longa demonstrated similar improvement in VAS for pain compared to placebo (MD: 27.02, 95% CI: 1.45 to 52.60, p=0.04; MD: 21.48, 95% CI: 1.78 to 41.18, p=0.03).
Conclusion
Curcuma longa benefits knee OA pain and function, being more effective than placebo and comparable to NSAIDs. Despite positive results, limitation and heterogeneity of the studies necessitates further research to explore optimal dosages and administration methods of Curcuma longa as therapeutic option for knee OA.

Keyword

Knee osteoarthritis; Curcuma; Visual Analog Scale; Western Ontario and McMaster Universities Arthritis Index

Figure

• 

  Figure 1 Flowchart of identification and screening process for eligible randomized controlled trials.

• 

  Figure 2 Detailed risk of bias among included randomized controlled trials.

• 

  Figure 3 Forest plot portraying VAS for pain. SD: standard deviation, IV: interval variable, CI: confidence interval, VAS: Visual Analog Scale.

• 

  Figure 4 Forest plot portraying WOMAC total score of Curcuma longa vs. placebo-controlled group. SD: standard deviation, IV: interval variable, CI: confidence interval, WOMAC: Western Ontario and McMaster Universities Arthritis Index.

• 

  Figure 5 Forest plot portraying WOMAC total score of Curcuma longa vs. NSAIDs-controlled group. SD: standard deviation, IV: interval variable, CI: confidence interval, NSAIDs: nonsteroidal anti-inflammatory drugs, WOMAC: Western Ontario and McMaster Universities Arthritis Index.

• 

  Figure 6 Funnel plot, left to right of (A) VAS for pain score, (B) WOMAC total score. VAS: Visual Analog Scale, WOMAC: Western Ontario and McMaster Universities Arthritis Index, SE: standard error, MD: mean differences.

Reference

1. Feng J, Li Z, Tian L, Mu P, Hu Y, Xiong F, et al. 2022; Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 22:276. DOI: 10.1186/s12906-022-03740-9. PMID: 36261810. PMCID: PMC9580113.

2. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2020; 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 72:220–33. DOI: 10.1002/art.41142. PMID: 31908163. PMCID: PMC10518852.

3. Moseng T, Vliet Vlieland TPM, Battista S, Beckwée D, Boyadzhieva V, Conaghan PG, et al. 2024; EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 83:730–40. DOI: 10.1136/ard-2023-225041. PMID: 38212040. PMCID: PMC11103326.

4. Mora JC, Przkora R, Cruz-Almeida Y. 2018; Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 11:2189–96. DOI: 10.2147/JPR.S154002. PMID: 30323653. PMCID: PMC6179584.

5. Gomes TPO, Souza JIN, Somerlate LC, Mendonça VA, Lima NM, Carli GP, et al. 2021; Miconia albicans and Curcuma longa herbal medicines positively modulate joint pain, function and inflammation in patients with osteoarthritis: a clinical study. Inflammopharmacology. 29:377–91. DOI: 10.1007/s10787-020-00781-9. PMID: 33452967.

6. Zeng L, Yang T, Yang K, Yu G, Li J, Xiang W, et al. 2022; Efficacy and safety of curcumin and Curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial. Front Immunol. 13:891822. DOI: 10.3389/fimmu.2022.891822. PMID: 35935936. PMCID: PMC9353077.

7. Perhimpunan Reumatologi Indonesia. 2023. Diagnosis dan Pengelolaan. Osteoartritis. Perhimpunan Reumatologi Indonesia;Jakarta:

8. Lindler BN, Long KE, Taylor NA, Lei W. 2020; Use of herbal medications for treatment of osteoarthritis and rheumatoid arthritis. Medicines (Basel). 7:67. DOI: 10.3390/medicines7110067. PMID: 33126603. PMCID: PMC7693010.

9. Kumar S, Singh NN, Singh A, Singh N, Sinha RK. 2014; Use of Curcuma longa L. extract to stain various tissue samples for histological studies. Ayu. 35:447–51. DOI: 10.4103/0974-8520.159027. PMID: 26195911. PMCID: PMC4492033.

10. Iweala EJ, Uche ME, Dike ED, Etumnu LR, Dokunmu TM, Oluwapelumi AE, et al. 2023; Curcuma longa (Turmeric): ethnomedicinal uses, phytochemistry, pharmacological activities and toxicity profiles-a review. Pharmacol Res. 6:100222. DOI: 10.1016/j.prmcm.2023.100222.

11. Fuloria S, Mehta J, Chandel A, Sekar M, Rani NNIM, Begum MY, et al. 2022; A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front Pharmacol. 13:820806. DOI: 10.3389/fphar.2022.820806. PMID: 35401176. PMCID: PMC8990857.

12. Gupta SC, Patchva S, Aggarwal BB. 2013; Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 15:195–218. DOI: 10.1208/s12248-012-9432-8. PMID: 23143785. PMCID: PMC3535097.

13. Ghotaslou R, Leylabadlo HE, Akhi MT, Sadeghi J, Yousefi L, et al. bialvaei AZ. 2017; The importance of Helicobacter pylori tnpA, tnpB, and cagA genes in various gastrointestinal diseases. Mol Genet Microbiol Virol. 32:62–5. DOI: 10.3103/S0891416817010049.

14. Sharma RA, Steward WP, Gescher AJ. 2007; Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 595:453–70. DOI: 10.1007/978-0-387-46401-5_20. PMID: 17569224.

15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003; Measuring inconsistency in meta-analyses. BMJ. 327:557–60. DOI: 10.1136/bmj.327.7414.557. PMID: 12958120. PMCID: PMC192859.

16. Higgins JP, Thompson SG. 2002; Quantifying heterogeneity in a meta-analysis. Stat Med. 21:1539–58. DOI: 10.1002/sim.1186. PMID: 12111919.

17. Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. 2016; Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology. 24:377–88. DOI: 10.1007/s10787-016-0289-9. PMID: 27761693.

18. Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. 2014; Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res. 28:1625–31. DOI: 10.1002/ptr.5174. PMID: 24853120.

19. Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, et al. 2014; Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci. 19:933–9. DOI: 10.1007/s00776-014-0633-0. PMID: 25308211. PMCID: PMC4244558.

20. Madhu K, Chanda K, Saji MJ. 2013; Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacology. 21:129–36. DOI: 10.1007/s10787-012-0163-3. PMID: 23242572.

21. Atabaki M, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohammadi M. 2020; Significant immunomodulatory properties of curcumin in patients with osteoarthritis; a successful clinical trial in Iran. Int Immunopharmacol. 85:106607. DOI: 10.1016/j.intimp.2020.106607. PMID: 32540725.

22. Henrotin Y, Malaise M, Wittoek R, de Vlam K, Brasseur JP, Luyten FP, et al. 2019; Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res Ther. 21:179. DOI: 10.1186/s13075-019-1960-5. PMID: 31351488. PMCID: PMC6661105.

23. Singhal S, Hasan N, Nirmal K, Chawla R, Chawla S, Kalra BS, et al. 2021; Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials. 22:105. DOI: 10.1186/s13063-021-05053-7. PMID: 33516238. PMCID: PMC7847013.

24. Shep D, Khanwelkar C, Gade P, Karad S. 2019; Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials. 20:214. DOI: 10.1186/s13063-019-3327-2. PMID: 30975196. PMCID: PMC6460672.

25. Correll DJ. Waldman SD, editor. 2007. The measurement of pain: objectifying the subjective. Pain management. Elsevier;Philadelphia: p. 197–211. DOI: 10.1016/B978-0-7216-0334-6.50022-4.

26. Ebrahimzadeh MH, Makhmalbaf H, Birjandinejad A, Keshtan FG, Hoseini HA, Mazloumi SM. 2014; The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in Persian speaking patients with knee osteoarthritis. Arch Bone Jt Surg. 2:57–62.

27. Barber-Westin SD, Noyes FR. Noyes FR, Barber-Westin SD, editors. 2017. Rating of athletic and daily functional activities: knee-specific scales and global outcome instruments. Noyes' knee disorders: surgery, rehabilitation, clinical outcomes. Elsevier;Philadelphia: p. 1211–21. DOI: 10.1016/B978-0-323-32903-3.00043-3.

28. Zhao J, Liang G, Zhou G, Hong K, Yang W, Liu J, et al. 2024; Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis. J Ethnopharmacol. 321:117493. DOI: 10.1016/j.jep.2023.117493. PMID: 38036015.

29. Akuri MC, Barbalho SM, Val RM, Guiguer EL. 2017; Reflections about osteoarthritis and Curcuma longa. Pharmacogn Rev. 11:8–12. DOI: 10.4103/phrev.phrev_54_16. PMID: 28503046. PMCID: PMC5414457.

30. Deng W, He Q, Zhang W. 2024; Analysis of the mechanism of curcumin against osteoarthritis using metabolomics and transcriptomics. Naunyn Schmiedebergs Arch Pharmacol. 397:3313–29. DOI: 10.1007/s00210-023-02785-y. PMID: 37938371. PMCID: PMC11074044.

31. Zhang Z, Leong DJ, Xu L, He Z, Wang A, Navati M, et al. 2016; Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res Ther. 18:128. DOI: 10.1186/s13075-016-1025-y. PMID: 27260322. PMCID: PMC4891896.

32. Swallow J, Seidler K, Barrow M. 2024; The mechanistic role of curcumin on matrix metalloproteinases in osteoarthritis. Fitoterapia. 174:105870. DOI: 10.1016/j.fitote.2024.105870. PMID: 38423225.

33. Sutipornpalangkul W, Morales NP, Harnroongroj T. 2009; Free radicals in primary knee osteoarthritis. J Med Assoc Thai. 92 Suppl 6:S268–74.

34. Onakpoya IJ, Spencer EA, Perera R, Heneghan CJ. 2017; Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Int J Rheum Dis. 20:420–33. DOI: 10.1111/1756-185X.13069. PMID: 28470851.

35. Chen W, Shi H, Deng P, Yang Z, Liu W, Qi L, et al. 2022; Quality of evidence supporting the role of curcuma longa extract/curcumin for the treatment of osteoarthritis: an overview of systematic reviews. Evid Based Complement Alternat Med. 2022:6159874. DOI: 10.37766/inplasy2022.2.0063. PMID: 35399636. PMCID: PMC8991401.

36. Seo EJ, Efferth T, Panossian A. 2018; Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. Phytomedicine. 50:285–99. DOI: 10.1016/j.phymed.2018.09.202. PMID: 30466988.

37. Dai W, Yan W, Leng X, Chen J, Hu X, Ao Y. 2021; Effectiveness of Curcuma longa extract versus placebo for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 35:5921–35. DOI: 10.1002/ptr.7204. PMID: 34216044.

38. Wang Z, Jones G, Winzenberg T, Cai G, Laslett LL, Aitken D, et al. 2020; Effectiveness of Curcuma longa extract for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Ann Intern Med. 173:861–9. DOI: 10.7326/M20-0990. PMID: 32926799.

39. Wright DF, Winter HR, Duffull SB. 2011; Understanding the time course of pharmacological effect: a PKPD approach. Br J Clin Pharmacol. 71:815–23. DOI: 10.1111/j.1365-2125.2011.03925.x. PMID: 21272054. PMCID: PMC3099368.

40. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, et al. 2014; Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 9:451–8. DOI: 10.2147/CIA.S58535. PMID: 24672232. PMCID: PMC3964021.

41. Kizhakkedath R. 2013; Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis. Mol Med Rep. 8:1542–8. DOI: 10.3892/mmr.2013.1661. PMID: 24002213.

42. Wang Z, Singh A, Jones G, Winzenberg T, Ding C, Chopra A, et al. 2021; Efficacy and safety of turmeric extracts for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomised controlled trials. Curr Rheumatol Rep. 23:11. DOI: 10.1007/s11926-020-00975-8. PMID: 33511486.

43. Hsiao AF, Lien YC, Tzeng IS, Liu CT, Chou SH, Horng YS. 2021; The efficacy of high- and low-dose curcumin in knee osteoarthritis: a systematic review and meta-analysis. Complement Ther Med. 63:102775. DOI: 10.1016/j.ctim.2021.102775. PMID: 34537344.

44. Mobasheri A, Henrotin Y, Biesalski HK, Shakibaei M. 2012; Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int J Mol Sci. 13:4202–32. DOI: 10.3390/ijms13044202. PMID: 22605974. PMCID: PMC3344210.

45. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, et al. 2010; Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 15:337–44.

46. Hewlings SJ, Kalman DS. 2017; Curcumin: a review of its effects on human health. Foods. 6:92. DOI: 10.3390/foods6100092. PMID: 29065496. PMCID: PMC5664031.